Questions, answered.

Exclusive country-level rights to operate hospitals under the ObesityHospitals™ brand, using our complete clinical, operational and commercial system. One licensee per country.

License fees begin at USD 100,000 and scale by territory according to population, healthcare spend and competitive density. Larger markets are priced accordingly.

Yes, with our written approval. Transfers are routinely granted to qualified successors and institutional buyers.

20% of gross revenue, paid monthly, for the life of the license. Our income is contingent on yours — we do not earn unless you do.

Yes. After year five, the licensee may exercise a one-time buyout at a pre-agreed multiple of trailing twelve-month EBITDA, releasing the territory from ongoing royalty obligations.

Through our clinical mix (bariatric surgery, GLP-1 programmes, endoscopic and pediatric pathways), pricing system and patient acquisition playbook — modelled on validated unit economics.

No. Most master licensees are investors, family offices or healthcare groups. Clinical leadership is recruited and trained under our protocols.

Brand, trademark, surgical SOPs, pharmacological protocols, architectural plans, equipment lists, EHR templates, training academy access, marketing system and ongoing consultancy.

Typical timeline is 9 to 14 months from license execution to first patient — depending on regulatory approvals and build pace.

ObesityHospitals™ is owned by the founding company. The license grants exclusive country-level use under the terms of the Master License Agreement.

Standard licenses are perpetual unless terminated for material breach. The buyout option does not terminate the license — it only releases the royalty.